Orion Biotechnology acquires patent portfolio for potent CCR5 chemokine antagonist
06 sept. 2018 13h08 HE
|
Orion Biotechnology Canada Ltd
OTTAWA, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that its subsidiary, Orion Biotechnology Switzerland Sàrl, has...